Spironolactone: diuretic or disease-modifying drug in heart failure with preserved ejection fraction?

Frederik H Verbrugge, Kevin Damman

Research output: Contribution to journalEditorial

1 Citation (Scopus)
Original languageEnglish
Pages (from-to)1611-1614
Number of pages4
JournalEuropean Journal of Heart Failure
Issue number9
Publication statusPublished - Sep 2020


  • Diuretics/therapeutic use
  • Heart Failure/drug therapy
  • Hospitalization
  • Humans
  • Mineralocorticoid Receptor Antagonists/therapeutic use
  • Pharmaceutical Preparations
  • Spironolactone/therapeutic use
  • Stroke Volume

Cite this